BACKGROUND/AIMS: Complex interplay of genetic and (patho)physiological factors influence availability of nitric oxide during the development and progression of diabetic complications. We assessed predictive value of commonly studied methylated asymmetric and symmetric dimethylarginines (ADMA and SDMA) and selected single nucleotide polymorphisms (SNPs) in dimethylarginine dimethylaminohydrolase (DDAH) 1 and 2 genes for the progression of diabetic nephropathy (DN). METHODS: A total of 341 type 1 and type 2 diabetes patients with variable degree of kidney disease were included at baseline. Plasma levels of ADMA, SDMA and L-arginine were measured and six tagging SNPs in DDAH1 and 2 were determined. Progression of DN was defined as a transition from any given stage to a more advanced stage of albuminuria. Competing risk analysis was applied. RESULTS: Plasma levels of ADMA and SDMA significantly correlated with GFR. No significant genotype-phenotype relationship was ascertained for ADMA and DDAH variants, but SNP rs805304 exhibited marginally significant association with DN. ADMA, SDMA and L-arginine/ADMA ratio standardised to GFR were identified as significant predictors of DN progression but not GFR decline using multivariate competing risk analysis. CONCLUSIONS: In our study we confirmed potentially significant role of ADMA and SDMA for the assessment of risk of DN progression in European diabetic population.

Dept of Pathophysiology Masaryk University Brno Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc14040982

003      

CZ-PrNML

005      

20190611093800.0

007      

ta

008      

140107s2012 sz f 000 0|eng||

009      

AR

024    7_

$a 10.1159/000343409 $2 doi

035    __

$a (PubMed)23147199

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a sz

100    1_

$a Tanhäuserová, Veronika $7 _AN049374 $u Dept. of Pathophysiology, Masaryk University Brno, Czech Republic

245    10

$a ADMA, SDMA and L-arginine/ADMA ratio but not DDAH genetic polymorphisms are reliable predictors of diabetic nephropathy progression as identified by competing risk analysis / $c V. Tanhäuserová, J. Tomandl, L. Pácal, M. Klepárník, D. Malúšková, V. Bartáková, K. Kuricová, J. Rehořová, S. Stěpánková, J. Svojanovský, J. Olšovský, J. Bělobrádková, D. Krusová, M. Jurajda, J. Mužík, T. Pavlík, K. Kaňková,

520    9_

$a BACKGROUND/AIMS: Complex interplay of genetic and (patho)physiological factors influence availability of nitric oxide during the development and progression of diabetic complications. We assessed predictive value of commonly studied methylated asymmetric and symmetric dimethylarginines (ADMA and SDMA) and selected single nucleotide polymorphisms (SNPs) in dimethylarginine dimethylaminohydrolase (DDAH) 1 and 2 genes for the progression of diabetic nephropathy (DN). METHODS: A total of 341 type 1 and type 2 diabetes patients with variable degree of kidney disease were included at baseline. Plasma levels of ADMA, SDMA and L-arginine were measured and six tagging SNPs in DDAH1 and 2 were determined. Progression of DN was defined as a transition from any given stage to a more advanced stage of albuminuria. Competing risk analysis was applied. RESULTS: Plasma levels of ADMA and SDMA significantly correlated with GFR. No significant genotype-phenotype relationship was ascertained for ADMA and DDAH variants, but SNP rs805304 exhibited marginally significant association with DN. ADMA, SDMA and L-arginine/ADMA ratio standardised to GFR were identified as significant predictors of DN progression but not GFR decline using multivariate competing risk analysis. CONCLUSIONS: In our study we confirmed potentially significant role of ADMA and SDMA for the assessment of risk of DN progression in European diabetic population.

650    _2

$a dospělí $7 D000328

650    _2

$a senioři $7 D000368

650    _2

$a amidohydrolasy $x genetika $7 D000581

650    _2

$a arginin $x analogy a deriváty $x krev $x genetika $7 D001120

650    _2

$a průřezové studie $7 D003430

650    _2

$a diabetes mellitus 1. typu $x komplikace $7 D003922

650    _2

$a diabetes mellitus 2. typu $x komplikace $7 D003924

650    12

$a diabetické nefropatie $x krev $x etiologie $x genetika $7 D003928

650    12

$a progrese nemoci $7 D018450

650    _2

$a ženské pohlaví $7 D005260

650    _2

$a následné studie $7 D005500

650    _2

$a lidé $7 D006801

650    _2

$a mužské pohlaví $7 D008297

650    _2

$a metylace $7 D008745

650    _2

$a lidé středního věku $7 D008875

650    _2

$a multivariační analýza $7 D015999

650    _2

$a jednonukleotidový polymorfismus $x genetika $7 D020641

650    _2

$a prediktivní hodnota testů $7 D011237

650    _2

$a prognóza $7 D011379

650    _2

$a reprodukovatelnost výsledků $7 D015203

650    _2

$a rizikové faktory $7 D012307

651    _2

$a Česká republika $7 D018153

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Tomandl, Josef, $u - $d 1964- $7 mzk2003175507

700    1_

$a Pácal, Lukáš $u - $7 xx0084072

700    1_

$a Klepárník, Martin $u - $7 xx0237043

700    1_

$a Krejčí, Denisa $u - $7 xx0232798

700    1_

$a Bartáková, Vendula $u - $7 xx0240193

700    1_

$a Chalásová, Katarína $u - $7 mub2017949800

700    1_

$a Řehořová, Jitka $u -

700    1_

$a Štěpánková, Soňa, $u - $d 1964- $7 xx0106210

700    1_

$a Svojanovský, Jan $u - $7 xx0103906

700    1_

$a Olšovský, Jindřich, $u - $d 1962- $7 nlk20060173684

700    1_

$a Bělobrádková, Jana $u - $7 mzk2007382258

700    1_

$a Krusová, Darja $u - $7 xx0143317

700    1_

$a Jurajda, Michal, $u - $d 1971- $7 xx0037784

700    1_

$a Mužík, Jan $u - $7 xx0133377

700    1_

$a Pavlík, Tomáš $u - $7 xx0093293

700    1_

$a Kaňková, Kateřina, $u - $d 1971- $7 mzk2003190820

773    0_

$w MED00003064 $t Kidney & blood pressure research $x 1423-0143 $g Roč. 36, č. 1 (2012), s. 200-208

856    41

$u https://pubmed.ncbi.nlm.nih.gov/23147199 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20140107 $b ABA008

991    __

$a 20190611093944 $b ABA008

999    __

$a ok $b bmc $g 1005378 $s 839494

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2012 $b 36 $c 1 $d 200-208 $i 1423-0143 $m Kidney & blood pressure research $n Kidney Blood Press Res $x MED00003064

GRA    __

$a NT11405 $p MZ0

LZP    __

$a Pubmed-20140107